ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,156 | -11.1% | 27,170 | +0.7% | 0.00% | – |
Q2 2023 | $62,059 | -15.4% | 26,982 | +11.4% | 0.00% | – |
Q1 2023 | $73,384 | +14.3% | 24,219 | -12.1% | 0.00% | – |
Q4 2022 | $64,210 | +36.6% | 27,558 | +12.4% | 0.00% | – |
Q3 2022 | $47,000 | -26.6% | 24,515 | +3.4% | 0.00% | – |
Q2 2022 | $64,000 | -31.2% | 23,713 | -23.7% | 0.00% | – |
Q1 2022 | $93,000 | -34.5% | 31,080 | -15.1% | 0.00% | – |
Q4 2021 | $142,000 | +5.2% | 36,599 | +16.3% | 0.00% | – |
Q3 2021 | $135,000 | +18.4% | 31,477 | -16.2% | 0.00% | – |
Q2 2021 | $114,000 | +192.3% | 37,580 | +219.8% | 0.00% | – |
Q1 2021 | $39,000 | -17.0% | 11,750 | -10.3% | 0.00% | – |
Q4 2020 | $47,000 | +104.3% | 13,104 | -14.9% | 0.00% | – |
Q3 2019 | $23,000 | -45.2% | 15,394 | -24.3% | 0.00% | – |
Q2 2019 | $42,000 | -48.1% | 20,342 | -10.3% | 0.00% | – |
Q1 2019 | $81,000 | -5.8% | 22,682 | +0.7% | 0.00% | -100.0% |
Q4 2018 | $86,000 | -66.1% | 22,521 | -16.3% | 0.00% | -50.0% |
Q3 2018 | $254,000 | +25.1% | 26,911 | -3.3% | 0.00% | +100.0% |
Q2 2018 | $203,000 | +59.8% | 27,835 | +9.4% | 0.00% | 0.0% |
Q1 2018 | $127,000 | -15.3% | 25,453 | -14.2% | 0.00% | 0.0% |
Q4 2017 | $150,000 | – | 29,660 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
Kepos Capital LP | 155,691 | $316 | 0.06% |
Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |